MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- DR. DATSONS LAB LIMITED (pharmaceuticals)
- Latest 8 Quarter Result
AANJANEYA LIFECARE Quarterly Results 
(ALCL)
Here are the latest quarterly results of AANJANEYA LIFECARE. For more details, see the AANJANEYA LIFECARE financial fact sheet and AANJANEYA LIFECARE share price and chart.
AANJANEYA LIFECARE Quarterly Results
| No. of Mths Qtr. Ending |
3
Mar-13 |
3
Jun-13 |
3
Sep-13 |
3
Dec-13 |
3
Mar-14 |
3
Jun-14 |
3
Sep-14 |
3
Dec-14 |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 739 | 1,177 | 1,320 | 1,506 | 208 | 2,014 | 1,140 | 1,711 | |
| Other income | Rs m | -6 | 0 | 0 | 0 | 78 | 0 | 44 | 49 | |
| Turnover | Rs m | 733 | 1,177 | 1,320 | 1,506 | 286 | 2,014 | 1,184 | 1,760 | |
| Expenses | Rs m | 677 | 969 | 1,150 | 1,300 | 221 | 1,914 | 1,084 | 1,659 | |
| Gross profit | Rs m | 62 | 208 | 170 | 206 | -13 | 100 | 56 | 52 | |
| Depreciation | Rs m | 54 | 51 | 52 | 52 | 50 | 12 | 13 | 13 | |
| Interest | Rs m | 99 | 117 | 83 | 127 | 103 | 87 | 87 | 88 | |
| Profit before tax | Rs m | -97 | 40 | 36 | 28 | -88 | 1 | 0 | 0 | |
| Tax | Rs m | -164 | 7 | 17 | 9 | -27 | 0 | 0 | 0 | |
| Profit after tax | Rs m | 67 | 33 | 19 | 19 | -62 | 1 | 0 | 0 | |
| Gross profit margin | % | 8.4 | 17.7 | 12.9 | 13.7 | -6.4 | 5.0 | 4.9 | 3.1 | |
| Effective tax rate | % | 169.1 | 17.5 | 46.6 | 32.4 | 30.2 | 31.0 | 32.1 | 29.0 | |
| Net profit margin | % | 9.1 | 2.8 | 1.5 | 1.2 | -29.6 | 0.0 | 0.0 | 0.0 | |
| Diluted EPS | Rs | 0.6 | 0.3 | 0.2 | 0.2 | -0.6 | 0.0 | 0.0 | 0.0 | |
| Diluted EPS (TTM) | Rs | 4.3 | 2.8 | 2.1 | 1.3 | 0.1 | -0.2 | -0.4 | -0.6 | |
 Subscriber Feature |
||||||||||
Interim results exclude extraordinary / exceptional items
More Pharmaceuticals Company Quarterly Results: TALWALKARS BETTER VALUE RUPA & CO. LINC PEN & PLASTICS TREE HOUSE RELAXO FOOTWEARS
Compare DR. DATSONS LABS With: TALWALKARS BETTER VALUE RUPA & CO. LINC PEN & PLASTICS TREE HOUSE RELAXO FOOTWEARS
|
| |
Today's Market
Indian Indices Trade on a Flat Note; Oil & Gas and Automobile Stocks Drag(12:30 pm)
Share markets in India are presently trading on a flat note. Sectoral indices are trading mixed with stocks in the oil & gas sector, automobile sector.
Views on news
MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)
Mar 13, 2019Should you subscribe to the IPO of MSPC Limited?
Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)
Mar 14, 2018Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?
Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)
Mar 12, 2018Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?
Apollo Micro Systems Ltd. (IPO)
Jan 9, 2018Should you subscribe to the IPO of Apollo Micro Systems Ltd?
Khadim India Ltd. (IPO)
Oct 31, 2017Should you subscribe to the IPO of Khadim India Ltd?
More Views on NewsMost Popular
7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)
Jun 13, 2019We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?
The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)
Jun 11, 2019One chart that predicted the NBFC crisis back in 2016.
Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)
Jun 12, 2019This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.
Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)
Jun 14, 2019Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.
7 Bluechips to Profit from Tech Disruption(Profit Hunter)
Jun 17, 2019We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?
More|
| |
DR. DATSONS LABS SHARE PRICE
May 21, 2015 (Close)
TRACK DR. DATSONS LABS
- Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON DR. DATSONS LABS
DR. DATSONS LABS - MYLAN COMPARISON
COMPARE DR. DATSONS LABS WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.